Follow
Siddhant Kadu
Siddhant Kadu
PhD student, Bioengineering, University of Pennsylvania
Verified email at seas.upenn.edu
Title
Cited by
Cited by
Year
Macrophages show higher levels of engulfment after disruption of cis interactions between CD47 and the checkpoint receptor SIRPα
BH Hayes, RK Tsai, LJ Dooling, S Kadu, JY Lee, D Pantano, ...
Journal of cell science 133 (5), jcs237800, 2020
442020
Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses
LJ Dooling, JC Andrechak, BH Hayes, S Kadu, W Zhang, R Pan, ...
Nature Biomedical Engineering 7 (9), 1081-1096, 2023
132023
Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function
C Zhang, S Kadu, Y Xiao, O Johnson, A Kelly, RS O'Connor, M Lai, ...
Cancer Immunology Research 11 (11), 1524-1537, 2023
42023
Cooperative phagocytosis underlies macrophage immunotherapy of solid tumours and initiates a broad anti-tumour IgG response
JC Andrechak, LJ Dooling, BH Hayes, S Kadu, W Zhang, R Pan, ...
biorxiv, 2022.01. 01.474150, 2022
42022
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy
Y Tang, W Liu, S Kadu, O Johnson, ZS Hasanali, A Kelly, A Shestov, ...
Blood 143 (2), 139-151, 2024
12024
Solid Tumor Cures by Complete Disruption of the CD47: SIRPα Macrophage Checkpoint, Tumor Opsonization, and ‘Phagocytic Feedback’
LJ Dooling, JC Andrechak, BH Hayes, S Kadu, R Pan, MP Tobin, ...
Biophysical Journal 120 (3), 89a, 2021
12021
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice
ZS Hasanali, A Garfall, L Burzenski, L Shultz, Y Tang, S Kadu, ...
bioRxiv, 2024.01. 21.576547, 2024
2024
Macrophages Aggregate and Cooperate to Phagocytose Cohesive Tumor Cell Targets in Engineered Immuno-Tumoroids and Solid Tumors
LJ Dooling, JC Andrechak, BH Hayes, S Kadu, DE Discher
2022 AIChE Annual Meeting, 2022
2022
Macrophages Cooperatively Phagocytose Solid Tumors in Macrophage Immunotherapy and Initiate an Anti-Tumor Antibody Feedback Loop
JC Andrechak, LJ Dooling, S Kadu, W Zhang, JY Lee, BH Hayes, R Pan, ...
MOLECULAR THERAPY 30 (4), 508-508, 2022
2022
Macrophage Checkpoint Blockade: From Cell Therapy and CRISPR Models to Acquired Immunity
LJ Dooling, JC Andrechak, BH Hayes, S Kadu, DE Discher
2020 Virtual AIChE Annual Meeting, 2020
2020
Adaptive Immune Responses Against Solid Tumors Mediated by Macrophage Checkpoint Blockade
JC Andrechak, LJ Dooling, BH Hayes, JY Lee, S Kadu, R Pan, ...
MOLECULAR THERAPY 28 (4), 153-153, 2020
2020
Mouse Melanoma B16 Tumors are Soft and Engulfable when Targeted in Combination with Macrophage Checkpoint Blockade
LJ Dooling, BH Hayes, JC Andrechak, S Kadu, DE Discher
Biophysical Journal 118 (3), 155a-156a, 2020
2020
Macrophages eat more after disruption of cis interactions between CD47 and the checkpoint receptor SIRPα
BH Hayes, RK Tsai, LJ Dooling, S Kadu, JY Lee, D Pantano, ...
MACROPHAGES & CHROMOSOMAL INSTABILITY, 1, 0
The system can't perform the operation now. Try again later.
Articles 1–13